MHRA fees
Fees payable to the MHRA from 2025.
Updates to this page
- From:
- Medicines and Healthcare products Regulatory Agency
- Published:
- 18 December 2014
- Last updated:
-
21 April 2026
Show all updates
-
Amended the costs for the Annual Compliance Report to align to regulation 22.
-
Updates to add new information under Medical Device Fees section 7d
-
Updated MHRA Fees document, point 6, notes, to reflect that there is no longer a phase IV notification scheme.
-
Updated to correct the following figures in the MHRA fees document: 38. Wholesale distribution authorisations: fees - New Applications - Reduced application* plus full inspection fee (£5,216 changed to £5,128) (£1,080 changed to £992) application fee plus £4,136 inspection fee 38. Wholesale distribution authorisations: fees - New Applications - Reduced application plus reduced Inspection fee - General Sales List (GSL) only (£3,148 changed to £3,060) (£1,080 changed to £992) application fee plus £2,068 inspection fee
-
Updated link to 'Apply for payment easement as an SME' form.
-
Page layout updated to make the content more accessible to users.
-
Updated the following fees sections to reflect increases from 16 July 2025: - 4. Blood banks: application fees for a Review Panel hearing - 5. Blood banks and other blood establishments: fees - 6. Blood facilities: contract laboratories fees - 9. Clinical investigations for devices: fees - 42. Medical Device Approved Body Fees - 44. Devices Regulatory Advice meeting (new section added) Also updated: Payment easements and waivers for small and medium companies
-
Updated fees payable to the MHRA from 2025.
-
Updated to include fees regarding International Recognition.
-
Amendment fees added to our 'Current MHRA fees' webpage.
-
Added links to Fees page: The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2023 & The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023
-
Updated MHRA fees for 2023 - 2024
-
Added link to application form to 'apply for Small and Medium Company status'.
-
CURRENT FEES UPDATED
-
Changes to MHRA fees for 2021 - 2022
-
Published a new version of the 'Payment Easements and Waivers for Small and Medium Companies, as a HTML document. This replaces the 'Payment Easements for Small Companies' PDF.
-
Update on the MHRA fees for Licence applications: marketing authorisations; Orphan Marketing Products: fees; Variations: licence variations application fees; Variations: licence variations applications groups fees; and Variations: Traditional Herbal Registration Scheme fees
-
Added new information on fees following the end of the transition period. This includes new sections on orphan marketing products, Pharmacovigilance (PV) Safety Reviews, pre-assessment (rolling review) fees, PMF and Vaccine Antigen Master File certification.
-
Amended text under 'Current MHRA fees' guidance. Section '13. Inspection: fees'.
-
We have updated the years references to the periodic fees
-
Update to confirm fee levels for 2020 to 2021 are remaining the same as 2019 to 2020
-
Minor amendment to the explanation of the Office Based Inspection Fee to include information that was left out by mistake.
-
Information about 2017/18 fees added to the page.
-
MHRA's fees changed on April 1 2016.
-
MHRA's fees change on April 1 2016. Uploaded a PDF of the changed fees.
-
First published.
-
Documents
Current MHRA fees
HTML
MHRA fees definitions
PDF, 148 KB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
Fees extracts
PDF, 124 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
Fees for new suppliers of defined simple active pharmaceutical ingredients (APIs)
PDF, 20.2 KB, 3 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
Details
The document attached lists MHRA fees from 2025 - 2027.